8 results
Map of proliferative blood disorders. 

By Ariella Coler-Reilly @ariellastudies

#Algorithm #classification #proliferative #blood #disorders #leukemia #hematology #oncology
ariellastudies #Algorithm ... #classification ... #leukemia #hematology ... #oncology #diagnosis ... #CML #CLL #AML
Blood Disorders - Markers and Differential Diagnosis Algorithm 
Acute
 • Myloid (AML) - CD13, CD33, CD34,
Algorithm Acute ... • Myloid (AML ... CD23, o CML ... #hematology #Markers ... #Algorithm
Congenital Heart Disorders - Classification and Differential Algorithm

- Amy Chung, MD, MSc @AmyChung 

#Congenital #Heart #Disorders
Congenital Heart Disorders ... - Classification ... - Amy Chung, ... #Diagnosis #Peds ... Pediatrics #Cardiology #Cyanotic
Algorithm regarding the diagnosis and treatment of Hereditary Hemochromatosis HH. 

Step 1: In the patient with
Algorithm regarding ... the diagnosis and ... normal, further evaluation ... disorders. ... SF of >1,000 μg/mL
Lymphomas and Lymphoproliferative Disorders - Differential Diagnosis Algorithm
Hodgkin Lymphoma ~40% - Characteristic For Reed-Sternberg (RS) Cells
- Differential Diagnosis ... Algorithm Hodgkin ... relapse - Amy ... #Classification ... pathophysiology #Hematology
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
hemoproliferative disorder ... PV, MDS, CML) Treatment ... transformation into MDS or AML ... • Treatment algorithms ... #hematology
Helpful Clinical Features in Evaluating Bleeding Disorders
Age of onset
 • Neonate - in 20% of haemophilias,
Clinical Features in Evaluating ... relatives (if all ... #History #peds ... #pediatrics #diagnosis ... #hematology #primarycare
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
current treatment algorithm ... myeloid leukemia (AML ... cytopenias and AML ... median age at diagnosis ... #algorithm #hematology